Last update 21 Aug 2025

D6PV

Overview

Basic Info

Drug Type
Synthetic peptide vaccine, Therapeutic vaccine, Protein drugs
Synonyms
COR 003 (Novo Nordisk)
Target
APOC3 x PDX1
Action
inhibitors, agonists
Mechanism
APOC3 inhibitors(Apolipoprotein C-III inhibitors), PDX1 agonists(pancreatic and duodenal homeobox 1 agonists)
Therapeutic Areas
Immune System DiseasesEndocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 1Hypertriglyceridemia
Inactive Indication-
Originator Organization
Corvidia Therapeutics, Inc.Corvidia Therapeutics, Inc.
Active Organization
Novo Nordisk A/SNovo Nordisk A/SNational Health & Medical Research CouncilNational Health & Medical Research Council
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with D6PV
Login to view more data
100 Translational Medicine associated with D6PV
Login to view more data
100 Patents (Medical) associated with D6PV
Login to view more data
1
Literatures (Medical) associated with D6PV
01 Apr 2020Nature reviews. Cardiology
Dual apoC-II mimetic and apoC-III antagonist for hypertriglyceridaemia
100 Deals associated with D6PV
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 1Preclinical
Australia
National Health & Medical Research CouncilNational Health & Medical Research Council
20 Jun 2023
HypertriglyceridemiaPreclinical
United States
Novo Nordisk A/SNovo Nordisk A/S
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free